Long‐term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty F Grados, C Depriester, G Cayrolle, N Hardy, H Deramond, P Fardellone Rheumatology 39 (12), 1410-1414, 2000 | 1002 | 2000 |
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice JC Souberbielle, JJ Body, JM Lappe, M Plebani, Y Shoenfeld, TJ Wang, ... Autoimmunity reviews 9 (11), 709-715, 2010 | 774 | 2010 |
Prevalence of rheumatoid arthritis in France: 2001 F Guillemin, A Saraux, P Guggenbuhl, CH Roux, P Fardellone, ... Annals of the rheumatic diseases 64 (10), 1427-1430, 2005 | 335 | 2005 |
Prevalence of spondyloarthropathies in France: 2001 A Saraux, F Guillemin, P Guggenbuhl, CH Roux, P Fardellone, ... Annals of the rheumatic diseases 64 (10), 1431-1435, 2005 | 320 | 2005 |
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis K Briot, B Cortet, T Thomas, M Audran, H Blain, V Breuil, L Chapuis, ... Joint Bone Spine 79 (3), 304-313, 2012 | 302* | 2012 |
Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis JT Harrington, LG Ste-Marie, ML Brandi, R Civitelli, P Fardellone, ... Calcified tissue international 74, 129-135, 2004 | 298 | 2004 |
Suggestions for managing pyogenic (non-tuberculous) discitis in adults F Grados, FX Lescure, E Senneville, RM Flipo, JL Schmit, P Fardellone Joint Bone Spine 74 (2), 133-139, 2007 | 264 | 2007 |
Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey F Guillemin, AC Rat, B Mazieres, J Pouchot, B Fautrel, L Euller-Ziegler, ... Osteoarthritis and cartilage 19 (11), 1314-1322, 2011 | 263 | 2011 |
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice S Bombardieri, AA Ruiz, P Fardellone, P Geusens, F McKenna, ... Oxford University Press 46 (7), 1191-1199, 2007 | 236 | 2007 |
Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database M Maravic, C Le Bihan, P Landais, P Fardellone Osteoporosis international 16, 1475-1480, 2005 | 233 | 2005 |
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients B Combe, J Benessiano, F Berenbaum, A Cantagrel, JP Daurès, ... Joint bone spine 74 (5), 440-445, 2007 | 224 | 2007 |
Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? A Ghazali, P Fardellone, A Pruna, A Atik, JM Achard, R Oprisiu, M Brazier, ... Kidney international 55 (6), 2169-2177, 1999 | 218 | 1999 |
Presence of autoantibodies to the glycolytic enzyme α‐enolase in sera from patients with early rheumatoid arthritis V Saulot, O Vittecoq, R Charlionet, P Fardellone, C Lange, L Marvin, ... Arthritis & Rheumatism 46 (5), 1196-1201, 2002 | 216 | 2002 |
The role of calcium supplementation in healthy musculoskeletal ageing: An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis … NC Harvey, E Biver, JM Kaufman, J Bauer, J Branco, ML Brandi, ... Osteoporosis international 28, 447-462, 2017 | 213 | 2017 |
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors C Roux, JY Reginster, J Fechtenbaum, S Kolta, A Sawicki, Z Tulassay, ... Journal of Bone and Mineral Research 21 (4), 536-542, 2006 | 203 | 2006 |
Effect of alcohol intake on bone mineral density in elderly women: the EPIDOS study O Ganry, C Baudoin, P Fardellone American journal of epidemiology 151 (8), 773-780, 2000 | 199 | 2000 |
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate O Bruyere, C Roux, J Detilleux, DO Slosman, TD Spector, P Fardellone, ... The Journal of Clinical Endocrinology & Metabolism 92 (8), 3076-3081, 2007 | 196 | 2007 |
Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years JY Reginster, O Bruyère, A Sawicki, A Roces-Varela, P Fardellone, ... Bone 45 (6), 1059-1064, 2009 | 191 | 2009 |
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis FE Cotté, P Fardellone, F Mercier, AF Gaudin, C Roux Osteoporosis international 21, 145-155, 2010 | 186 | 2010 |
Evaluation of the calcium content of diet by frequential self-questionnaire P Fardellone, JL Sebert, M Bouraya, O Bonidan, G Leclercq, C Doutrellot, ... Revue du Rhumatisme et des Maladies Osteo-articulaires 58 (2), 99-103, 1991 | 178 | 1991 |